Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tart cherry juice tested as natural sleep aid for seniors

NCT ID NCT06786494

Symptom relief Sponsor: Courtney Millar Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether drinking tart cherry juice can improve sleep in older adults with insomnia. Twenty people aged 65 and older drank cherry juice and a placebo for 4 weeks each while wearing a sleep tracker. Researchers checked if the study was easy to follow and measured sleep quality and related body chemicals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

20 people

The number who actually took part.

Started

Jan 2025

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Men and women aged ≥65 years * Self-reporting insomnia (e.g., trouble sleeping approximately 3 nights a week for at least 6 months and/or an Insomnia Severity Index score ≥ 10 points) * Usual bed-time between 8:00 pm and 1:00 am Exclusion Criteria: * Unwilling to follow the study protocol * Inability to properly use the wearable device, complete smartphone-based surveys, or follow the intervention protocol * Self-report of medically diagnosed sleep disorders except insomnia (e.g., sleep apnea) * Current and consistent use of sleep aids or hypnotic prescriptions (e.g., trazadone) * Self-report of cognitive impairment, dementia, or other neurological disorder * Are on unstable medications (i.e., change within the last 3 months) for other conditions * Have an allergy to the intervention products * Self-report history of diabetes * Current alcohol (Alcohol Use Disorders Identification Test ≥4 points33,34) or drug use disorder (Drug Abuse Screening Test,35,36 DAST-10\>2 points) * Are excessive caffeine drinkers (\>5 cups of caffeinated beverages a day) * Any other reason/condition the PI and investigative team believe this intervention would be unsafe

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Insomnia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

insomnia Parasomnias

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Insomnia Sleep problems

Contacts and locations

Locations

  • Hebrew Rehabilitation Center

    Roslindale, Massachusetts, 02131, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.